- Mastercard announces partnership with Bvnk to jointly build payment infrastructure supporting interoperability between fiat currencies and stablecoins
- Philip Morris International USA announced plans to establish a new Business Solutions Center in the Tampa Bay area of Florida.
- Cross-border payment infrastructure company Thunes announces expansion of stablecoin settlement capabilities by connecting to the Swift network
- Candel Therapeutics Reports Extended Survival Tail Observed in Trial of Aglatimagene Besadenovec (CAN-2409) in Advanced Non-Small Cell Lung Cancer Patients with Inadequate Response to Immune Checkpoint Inhibitors
- CervoMed Approaches Critical Deadline with Funds Depleting Ahead of Important Phase 3 Study
- Elbit Systems (ESLT) Surpasses Q4 Expectations for Earnings and Revenue
- Alibaba's $136 Share Price: Liquidity Assessment Before AI Transformation Results
- Iran war: Europe's corporate winners and losers revealed
- 3 Wall Street Picks We’re Not Entirely Convinced By
- Hyperliquid Strategies financial report: HYPE holdings reach 17.6 million tokens and approximately 3 million company shares repurchased
- YD Bio Limited CEO Dr. Ethan Shen Details Strategic Roadmap for Integrated Oncology Ecosystem
- VisionWave Subsidiary SolarDrone Acquires Controlling Interest in Junko Solar and Appoints Industry Executive as CEO
- Acumen Pharmaceuticals Presents Studies on Enhanced Brain Delivery, Biomarker Research, and Novel Antibodies at Advances in Alzheimer's Treatment at International Conference on Alzheimer's and Parkinson's Diseases 2026
- CCC Intelligent Solutions Adds VSSTA to Diagnostics Network
- Enhanced Capital Named to the ImpactAssets 50 2026, the Definitive Guide to Impact Investing Fund Managers
- MMA.INC Launches Gear and Apparel Revenue Platform in Partnership with Zebra Athletics
- Elicio Therapeutics Reports Inducement Grants
- LENZ Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights on March 24, 2026
- Abacus Global Management to Participate in the 38th Annual Roth Conference
- Rapid7 Advances 2026 PACT Partner Program to Strengthen Partner Led Go-to-Market and Profitability
- AXIL Brands Unveils New Monster Jam Series Earplugs: X20i and X30i Models Featuring Iconic Truck Designs
- Daxor Corporation to Showcase Next-Generation Portable Blood Volume Analyzer at ACC.26; Highlighting Clinical Outcomes and Reduced Readmissions
- Nuwellis Completes Acquisition of Rendiatech
- Humacyte Submits Marketing Authorization Application for Symvess in Israel for Vascular Trauma Repair
- Fusion Fuel (HTOO) Highlights Royal Uranium's Cameco-Operated Uranium Royalty (2.0% NSR) in Canada's Athabasca Basin
- Elutia to Present at Sidoti's Small-Cap Virtual Investor Conference March 18-19
- Incannex Regains Compliance with Nasdaq Minimum Bid Price Requirement
- Esperion to Present Two New Analyses from CLEAR Outcomes Clinical Trial at the American College of Cardiology 2026 Annual Scientific Session
- Verity and CIBO Partner to Deliver End-to-End 45Z Compliance Solution for Biofuel Producers
- Tianci International, Inc. Announces Reverse Stock Split
- CareCloud to Participate in the 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum
- Galectin Therapeutics Strengthens Board of Directors with Appointment of Henry Brem, M.D.
- Youxin Technology Ltd Completes Strategic Asset Acquisition in Hainan Free Trade Port to Accelerate International Market Expansion
- Is Morgan Stanley Inst Global Opp I (MGGIX) Currently a Top Choice for Mutual Fund Investors?
- Is JPMorgan Small Cap Blend A (VSCOX) Currently a Top Choice Among Mutual Funds?
- PayPal's PYUSD Growth: An Examination of Its Movement
- Is Vanguard Total International Stock Index AD (VTIAX) Currently a Top Choice Among Mutual Funds?
- Core Scientific Stock Experiences Fluctuations Due to Institutional Movements and Accounting Errors
- Renewables Cushion Europe's Power Prices From Iran Shock
- 2 Dividend Stocks with Strong Financials and 1 We’re Cautious About
- Aurum brings in Nick Patel to deepen its RWA push
- Cari picks ZKsync’s Prividium as US regional banks join stablecoin race
- Iran Ramps Up Missile Strikes as Gulf States Face Escalating Danger
- Cypherpunk financial report discloses holding 294,743.1 ZEC
- Analyst Says Hyperliquid Isn’t A Buy Right Now: Here’s Why
- 3 Growth Stocks Worth Buying and Keeping for the Long Term
- Jefferies Sees 20% Growth Potential for MasTec Amid Changing U.S. Energy Demand
- S&P 500 Reaches Valuation Highs, Indicating Potential Downturn as 9 Out of 10 Major Indicators Suggest 'Sell'
- Orbs' March 17 Launch: Volume and Liquidity Metrics
- 1 Profitable Equity Boasting Strong Market Edge and 2 Encountering Challenges
- UK lawmakers question Lloyds over account glitch that exposed customers' details
- U.S. Changes in Crypto Regulation Impact Market Transparency and Supervisory Structures
- SK Hynix: The 2030 Supply Gap Argument Compared to Upcoming Price Trends
- 3 Leading Northern Mutual Funds to Consider Including in Your Portfolio Today
- Silver Holds Steady Above $80 as Market Focuses on Key Support and Resistance
- US Stocks Movement | Airline stocks surge pre-market, Delta Air Lines up nearly 5%
- 1 Stock with Strong Fundamentals but Lacking Profitability and 2 with Disappointing Performance
- 2 Digital Currencies Worth Purchasing During the Significant Market Downturn
- Middle East crude premiums surge to $56 per barrel—What this supply-demand disparity means for a critical Platts Dubai trading scenario
- Crypto Treasury Movements: Key Figures Driving Leadership Compensation and Share Price Growth
- Tokenized gold attracts increasing interest from institutions as the blockchain-powered precious metals sector continues to grow
- Israel’s Exports Drop Sharply as Conflict Disrupts Trade Routes
- Germany’s gas price cap legislation is putting pressure on the market—savvy investors are wagering on which companies will make it through
- Vireo’s merger and acquisition strategy has already been factored into its valuation—successful implementation is now the crucial turning point.
- Can-Fite Expands Namodenoson anti-Obesity Franchise with Israeli Patent Allowance
- Fusemachines to Participate in the 38th Annual ROTH Conference
- JPMorgan reports cautious investor flows amid Iran conflict escalation
- Futures Hotspot Tracking
- 10x Research: BTC and ETH rebound significantly, but heavy positions in crypto stocks are not recommended
- ImmunityBio, Inc. (NASDAQ: IBRX) announced today that the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology have been updated to officially include Anktiva (generic name: N-803) in combination with BCG as a treatment option for BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) patients presenting solely with papillary disease.
- Infineon executive urges Europe to build larger, automated fabs
- Stryker says cyberattack on its network contained
- ImmunityBio, Inc. (NASDAQ: IBRX) announced today that the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology have been updated to officially include Anktiva (generic name: N-803) in combination with BCG as a treatment option for BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) patients presenting only with papillary disease.
- Houthis: Iran Conflict to End Soon, Tankers to Begin Passage Through Strait of Hormuz
- PMAX Spikes on REE Results but Volume Fails to Confirm
- Gold’s Paper Market Squeeze Masking Strong Structural Demand as Central Banks Buy On
- Gold’s Paper Market Crunch Conceals Robust Underlying Demand Driven by Central Bank Purchases
- New Top Buy Recommendations for March 17th
- Bitget Experiences Rapid Growth in Tokenized Stock Trading: Trading Volume and Market Share
- 2 Lucrative Stocks with Strong Market Edges and 1 Encountering Challenges
- X4 Pharmaceuticals: Fourth Quarter Earnings Overview
- Knight Therapeutics has officially submitted supplemental registration applications for Minjuvi® (Tafasitamab) to the pharmaceutical regulatory agencies in Argentina and Mexico for the treatment of follicular lymphoma.
- Lumen Technologies recently announced a major executive appointment: retired Air Force General Kevin P. Chilton has been nominated as the company's next Chairman of the Board. This appointment will officially take effect after the conclusion of the 2026 Annual Shareholders Meeting.
- The latest financial data released by biotechnology company Abeona Therapeutics Inc shows its annual operating income recorded at -89.448 millions USD.
- POET Technologies Inc and Lessengers announce the expansion of their strategic partnership, jointly launching high-performance 1.6T 2×DR4 optical transceivers for AI network connectivity.
- Oil prices are the obvious threat, while credit is the hidden danger—which one will bring down the Federal Reserve first?
- "Wood Sister": Artificial intelligence has already improved labor productivity
- "Wood Sister": Artificial intelligence has already improved labor productivity
- Bank of America survey: Investors' expectations for a steeper yield curve have decreased
- USD: Peak fear debate on Strait risks – BBH
- XRP Latest Rally Fuels $618K Gains for Major Trader With $7.73M Long Position
- What Crypto Whales Are Buying and Selling Ahead of the March FOMC Meeting
- Hyperliquid price breaks key resistance as HYPE eyes $50 target
- Monte Rosa Therapeutics: Fourth Quarter Financial Results Overview
- Abeona Therapeutics: Fourth Quarter Earnings Overview
- Abeona Therapeutics: Fourth Quarter Earnings Overview
- Germany’s pursuit of data center “sovereignty” meets power grid limitations: Implementation trails behind AI-driven goals
- Arauco’s $4.6 Billion Pulp Mill Confronts Rising Debt and Biodiversity Threats with No Institutional Stake Involved
- Berkshire's Forever 3: Buffett-Backed Moats in Coca-Cola, American Express, and Moody's Set for Decades of Compounding
- SANTOSBTC Surges on Late-Night Breakout, RSI Nears Overbought
